Medicine and Dentistry
Colorectal Carcinoma
100%
Robot-Assisted Surgery
85%
Tissue Inhibitor of Metalloproteinase 1
85%
Biological Marker
85%
Oropharynx Squamous Cell Carcinoma
85%
Urokinase Receptor
85%
Head and Neck Cancer
85%
Malignant Neoplasm
85%
Wart Virus
64%
Platelet
28%
Radiation Therapy
21%
Cancer Surgery
21%
Randomized Clinical Trial
21%
Adenoma
15%
Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
85%
Transoral Robotic Surgery
85%
Head-and-neck Cancer
85%
Nonmalignant
85%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
85%
Analytical Considerations
85%
Colorectal Cancer
85%
High-risk Human Papillomavirus (HR-HPV)
42%
Colorectal Cancer Patients
22%
Long-term Functional Outcome
21%
Human Papillomavirus Negative
21%
Radiation Therapy
21%
Randomized Clinical Trial
21%
Better Prognosis
21%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Urokinase Receptor
85%
Biological Marker
85%
Tissue Inhibitor of Metalloproteinase 1
85%
Biological Variation
85%
Malignant Neoplasm
85%
Adenoma
15%